Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Fibroadenoma × gadoterate meglumine × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Brain Neoplasms 3 Carcinoma, Hepatocellular 2 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Glioma 1 Fibroadenoma 1 Colorectal Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Diseases 1

Interventions

Tamoxifen 2 gadoterate meglumine 1 evening primrose oil 1 Surgical Procedures, Operative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04341129 2023-12-05

Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)

University of Chicago

Phase EARLY_PHASE1 Completed

Breast Diseases, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Fibroadenoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡